Rosiglitazone and metformin vs CYP2C8 Inducers (Highly Effective)

Interacting Drugs
Rosiglitazone and metformin
vs
CYP2C8 Inducers (Highly Effective)
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C8 Inducers (Highly Effective): May increase the metabolism of CYP2C8 Substrates (High risk).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Rosiglitazone and metformin vs CYP2C8 Inducers (Highly Effective)